GŁUSZCZYK, Agnieszka et al. Challenges and risks of using GLP-1 antagonists in treating type 2 diabetes and obesity. Quality in Sport, [S. l.], v. 17, p. 53683, 2024. DOI: 10.12775/QS.2024.17.53683. Disponível em: https://apcz.umk.pl/QS/article/view/53683. Acesso em: 25 dec. 2025.